Mireca Medicine

Mireca Medicine aims to bring its targeted small molecule drug candidate to patients suffering from incurable hereditary retinal diseases.

Mireca Medicine is a company in health care, medical based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2017.

Mireca Medicine is positioned in health care, medical, a segment that rewards a clear, focused offering.

The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).

Its current recorded stage is Series_Unknown.

Website: www.mireca.eu